- World rank, 2022–2025
- #17,866 of 28,054 · #22,460 all time
- Rank in India
- #1,203 of 1,840
- Research works
- 276 ▲ 86% vs 2013–17
- Citations
- 4.9k 17.7 per fractional work
- Top-10% rate
- 14.1% record average 16.5%
- Open access
- 54% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 13.3×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 13.3×
- Chemistry 3.6×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Medicine 2.1×
- Neuroscience 2.0×
- Materials Science 1.9×
- Decision Sciences 1.6×
- Dentistry 1.4×
- Immunology and Microbiology 1.3×
- Computer Science 1.1×
- Nursing 0.8×
- Agricultural and Biological Sciences 0.6×
- Chemical Engineering 0.6×
- Energy 0.4×
- Psychology 0.4×
- Economics, Econometrics and Finance 0.3×
- Mathematics 0.3×
- Health Professions 0.2×
- Arts and Humanities 0.2×
- Engineering 0.2×
- Business, Management and Accounting 0.1×
- Environmental Science 0.1×
- Social Sciences 0.1×
Who are the top researchers at Sun Pharma Advanced Research (India)?
Ranked on the composite score, Heather Joseph lead among researchers whose main affiliation is Sun Pharma Advanced Research (India).
- 1 Heather Joseph India · #924,294 worldwide 8 citations · 22 works
Which keywords describe research at Sun Pharma Advanced Research (India)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Nanoparticles, Drug Delivery, Inflammation, Metabolic Syndrome, Cancer Therapy, Insulin Resistance, Biomedical Applications and Tumor Targeting.
- Green Chemistry
- Antiepileptic Drugs
- Weight Loss
- Solid Dispersions
- Cyclodextrins
- Gene Therapy
- Open Educational Resources
- Medicinal Chemistry
- Hepatic Steatosis
- Toxicology
- Anti-inflammatory
- Antioxidant
- Clinical Trials
- Neurological Disorders
- Cardiovascular Disease
- Oxidative Stress
- Insulin Resistance
- Biomedical Applications
- Drug Delivery
- Epidemiology
- Inflammation
- Nanoparticles
- Metabolic Syndrome
- Cancer Therapy
- Obesity
- Tumor Targeting
- Nanocarriers
- Surface Engineering
- Drug Discovery
- Diabetes
- Pharmacokinetics
- Flavonoids
- Learning Object Repositories
- Neuroscience
- Drug Resistance
- Inflammatory Cytokines
- Model Organism
- Type 2 Diabetes
- Zebrafish
- Dry Eye Disease
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation7▲ 3.8×28 topics
- Epidemiology6▲ 1.82×28 topics
- Nanoparticles6▲ 5.8×12 topics
- Drug Delivery5▲ 11×7 topics
- Metabolic Syndrome5▲ 6.7×11 topics
- Biomedical Applications4▲ 4.5×8 topics
- Cancer Therapy4▲ 8.7×4 topics
- Insulin Resistance4▲ 10×8 topics
- Obesity4▲ 5.5×12 topics
- Oxidative Stress4▲ 2.5×14 topics
- Tumor Targeting3▲ 23×3 topics
- Cardiovascular Disease3▲ 3.1×10 topics
- Nanocarriers3▲ 61×1 topic
- Neurological Disorders3▲ 6.0×5 topics
- Surface Engineering3▲ 38×1 topic
- Clinical Trials2▲ 4.4×9 topics
- Drug Discovery2▲ 13×5 topics
- Antioxidant2▲ 3.8×10 topics
- Diabetes2▲ 5.3×8 topics
- Anti-inflammatory2▲ 8.1×8 topics
- Pharmacokinetics2▲ 8.8×4 topics
- Toxicology2▲ 13×3 topics
- Flavonoids2▲ 8.4×4 topics
- Hepatic Steatosis2▲ 14×2 topics
- Learning Object Repositories2▲ 234×1 topic
- Medicinal Chemistry2▲ 7.7×4 topics
- Neuroscience2▲ 7.4×3 topics
- Open Educational Resources2▲ 234×1 topic
- Drug Resistance2▲ 7.0×4 topics
- Gene Therapy2▲ 10×4 topics
- Inflammatory Cytokines2▲ 23×2 topics
- Cyclodextrins2▲ 86×1 topic
- Model Organism2▲ 141×1 topic
- Solid Dispersions2▲ 86×1 topic
- Type 2 Diabetes2▲ 7.8×4 topics
- Weight Loss2▲ 11×4 topics
- Zebrafish2▲ 86×1 topic
- Antiepileptic Drugs1▲ 22×2 topics
- Dry Eye Disease1▲ 51×1 topic
- Green Chemistry1▲ 9.7×4 topics
Which research topics does Sun Pharma Advanced Research (India) publish most on?
By volume in 2022–2025: Nanoparticle-Based Drug Delivery, Open Education and E-Learning, Drug Solubulity and Delivery Systems and Zebrafish Biomedical Research Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Nanoparticle-Based Drug Delivery Biomaterials 3 works
- 2 Open Education and E-Learning Computer Science Applications 2 works
- 3 Drug Solubulity and Delivery Systems Pharmaceutical Science 2 works
- 4 Zebrafish Biomedical Research Applications Cell Biology 2 works
- 5 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 1 works
- 6 Liver Disease Diagnosis and Treatment Epidemiology 1 works
- 7 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
- 8 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 1 works
- 9 Epilepsy research and treatment Psychiatry and Mental health 1 works
- 10 RNA Interference and Gene Delivery Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sun Pharma Advanced Research (India)'s research output changed?
Output in 2018–2022 was 86% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mumbai
- Indian Institute of Technology Bombay
- Bhabha Atomic Research Centre
- Tata Institute of Fundamental Research
- University of Mumbai
- Institute of Chemical Technology
- Homi Bhabha National Institute
- Tata Memorial Hospital
- Narsee Monjee Institute of Management Studies
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.